COST OF BEST SUPPORTIVE CARE FOR NON-SMALL CELL LUNG CANCER PATIENTS - A GERMAN PERSPECTIVE

被引：1
|
作者：
Schmidt, U. [1 ]
Lipp, R. [2 ]
Drechsler, M. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[2] GermanOncol, Hamburg, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2244
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN86
引用
收藏
页码：A629 / A629
页数：1
相关论文
共 50 条
  • [1] Prognostic factor of patients with advanced non-small cell lung cancer receiving best supportive care
    Kishikawa, Takayuki
    Masuda, Shingo
    Oda, Shinya
    Yamaguchi, Keisuke
    Furusato, Yuichiro
    Furusato, Ayaka
    Yamaguchi, Shota
    Inoue, Shigehiro
    Yasaka, Takahiro
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
    Numico, G
    Russi, E
    Merlano, M
    LUNG CANCER, 2001, 32 (03) : 213 - 226
  • [3] Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in Jordan
    Al Rabayah, Abeer
    Al Froukh, Rawan
    Sawalha, Razan
    Al Shnekat, Maali
    Jahn, Beate
    Siebert, Uwe
    Jaddoua, Saad M.
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
  • [4] Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients
    Kitazawa, Haruna
    Takeda, Yuichiro
    Naka, Go
    Sugiyama, Haruhito
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients
    Haruna Kitazawa
    Yuichiro Takeda
    Go Naka
    Haruhito Sugiyama
    Scientific Reports, 9
  • [6] Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Zhong, Chenxi
    Liu, Hongcheng
    Jiang, Liyan
    Zhang, Wei
    Yao, Feng
    PLOS ONE, 2013, 8 (03):
  • [7] COST-UTILITY OF CHEMOTHERAPY AND BEST SUPPORTIVE CARE IN NON-SMALL-CELL LUNG-CANCER
    KENNEDY, W
    REINHARZ, D
    TESSIER, G
    CONTANDRIOPOULOS, AP
    TRABUT, I
    CHAMPAGNE, F
    AYOUB, J
    PHARMACOECONOMICS, 1995, 8 (04) : 316 - 323
  • [8] Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer
    Burdett, Sarah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [9] The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer
    de Oliveira, Thiago Bueno
    Fontes, Debora Maloni Nasti
    Montella, Tatiane Caldas
    Lewgoy, Jairo
    Dutra, Carolina
    Miola, Thais Manfrinato
    CURRENT ONCOLOGY, 2024, 31 (01) : 183 - 202
  • [10] COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND
    Rutkowski, J.
    Gwiosda, B.
    Lisiecka, B.
    Wladysiuk, M.
    Lis, J.
    Plisko, R.
    Rys, P.
    VALUE IN HEALTH, 2009, 12 (07) : A280 - A280
12345